CD163 and hematoma: Adoptive transfer experiments further confirmed that Tregs promoted hematoma resolution by upregulating efferocytosis-related receptors (MERTK and AXL), ligands (Gas6 and C1q), and the hemoglobin scavenger receptor CD163.